New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.

Frontiers Genetically Modified T Cells for Esophageal Cancer

Gastric Cancer Therapy Market Size & Share Analysis - Industry

BIOSTAGE, INC. 2021 FORM 10-K

Breakthrough in treatment for stomach and esophageal cancer

Japanese firm's AI algorithm for gastric cancer gets FDA's

Mayo Clinic Q&A podcast: Esophageal cancer is one of the deadliest

The Future of Ovarian Cancer Treatment with Antibody-Drug

Frontiers Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China

New Gastric & Esophageal Cancer Treatment Breakthrough

Esophageal Cancer Treatment (PDQ®) - PDQ Cancer Information

Scientists make cancer breakthrough that could improve immunotherapy success rate

Progress of Gastric Cancer Surgery in the era of Precision Medicine

Cancers, Free Full-Text

Full article: From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer

Treatment strategies for patients with HER2-positive gastric